Literature DB >> 6742919

Fibre glass induced synovitis.

L G Cleland, B Vernon-Roberts, K Smith.   

Abstract

Chronic synovitis developed in the dorsal extensor sheath of the hand of a 25-year-old manufacturer of fibre glass reinforced boats and surfboards . Particles found in synovial fluid aspirates were similar in morphology and elemental content to unused fibre glass and particles found in dust from the workshop floor. It was concluded that hard disc grinding required during manufacture resulted in percutaneous implantation of small glass particles, leading to chronic synovitis and effusion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6742919      PMCID: PMC1001389          DOI: 10.1136/ard.43.3.530

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  4 in total

1.  Synovial fluid crystals.

Authors:  P A Dieppe; P R Crocker; C F Corke; D V Doyle; E C Huskisson; D A Willoughby
Journal:  Q J Med       Date:  1979-10

2.  Mechanisms of mesothelioma induction with asbestos and fibrous glass.

Authors:  M F Stanton; C Wrench
Journal:  J Natl Cancer Inst       Date:  1972-03       Impact factor: 13.506

3.  The effects of milling on diameters and lengths of fibrous glass and chrysotile asbestos fibers.

Authors:  J Assuncao; M Corn
Journal:  Am Ind Hyg Assoc J       Date:  1975-11

4.  Mortality of workers in the man-made mineral fibre industry.

Authors:  P E Enterline; G M Marsh
Journal:  IARC Sci Publ       Date:  1980
  4 in total
  2 in total

1.  Professor Barrie Vernon-Roberts, AO, MD, BSc, PhD, FRCPath, FRCPA, FAOrthA (Hon), FRS.SA.

Authors:  K D Rainsford; D R Haynes
Journal:  Inflammopharmacology       Date:  2013-07-04       Impact factor: 4.473

2.  Silicon-containing particles in synovial fluid: scanning electron microscopy coupled with analytical techniques allows an easy identification and differentiation from pathologically relevant crystals.

Authors:  G Faure; P Netter; M C Bene
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.